Elder Pharmaceuticals Financials
NSE: ELDERPHARM | BSE: 532322
₹38.00
₹1.80
(4.97%)
As on 12-Sep-2016IST
Market cap
₹78 Cr
Revenue (TTM)
₹633 Cr
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
633.35
|
1,008.91
|
1,641.70
|
1,334.78
|
965.28
|
721.60
|
|
|
|
|
|
|
Total Income
|
646.79
|
1,034.57
|
1,674.40
|
1,361.33
|
973.94
|
730.18
|
|
|
|
|
|
|
Total Expenditure
|
849.21
|
1,088.10
|
1,368.36
|
1,135.76
|
794.76
|
603.46
|
|
|
|
|
|
|
EBITDA
|
-215.86
|
-79.19
|
273.34
|
199.02
|
170.52
|
118.15
|
|
|
|
|
|
|
Depreciation
|
36.97
|
36.13
|
44.08
|
33.98
|
28.73
|
17.19
|
|
|
|
|
|
|
EBIT
|
-252.83
|
-115.31
|
229.26
|
165.04
|
141.79
|
100.95
|
|
|
|
|
|
|
Interest
|
210.70
|
275.63
|
154.83
|
101.57
|
65.51
|
53.02
|
|
|
|
|
|
|
Other Income
|
13.44
|
25.66
|
32.70
|
26.54
|
8.66
|
8.58
|
|
|
|
|
|
|
Exceptional Items
|
--
|
371.27
|
-2.83
|
1.49
|
-4.52
|
--
|
|
|
|
|
|
|
Profit before Tax
|
-76.93
|
5.99
|
104.31
|
91.51
|
80.41
|
56.51
|
|
|
|
|
|
|
Provision for Tax
|
--
|
12.52
|
21.92
|
19.25
|
16.86
|
9.29
|
|
|
|
|
|
|
Profit after Tax
|
-79.91
|
-6.53
|
82.39
|
72.26
|
63.55
|
47.22
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
0.68
|
2.28
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
-79.91
|
-6.53
|
82.39
|
72.26
|
64.22
|
49.50
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
702.39
|
773.35
|
769.26
|
700.59
|
630.66
|
480.48
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
3.06
|
10.39
|
|
|
|
|
|
|
Non-Current Liabilities
|
426.11
|
515.08
|
723.39
|
603.44
|
527.47
|
577.67
|
|
|
|
|
|
|
Current Liabilities
|
735.29
|
999.77
|
999.83
|
695.74
|
580.28
|
123.77
|
|
|
|
|
|
|
Total Liabilities
|
1,863.78
|
2,288.20
|
2,492.48
|
1,999.78
|
1,741.46
|
1,192.31
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,287.77
|
1,364.20
|
1,613.34
|
1,121.57
|
913.67
|
605.38
|
|
|
|
|
|
|
Current Assets
|
576.01
|
924.00
|
879.13
|
878.21
|
827.79
|
586.93
|
|
|
|
|
|
|
Total Assets
|
1,863.78
|
2,288.20
|
2,492.48
|
1,999.78
|
1,741.46
|
1,192.31
|
|
|
|
|
|
|
Total Debt*
|
--
|
847.62
|
1,343.67
|
1,080.59
|
901.05
|
573.86
|
|
|
|
|
|
|
Net Current Assets
|
-159.28
|
-75.77
|
-120.69
|
182.47
|
247.51
|
463.17
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
157.84
|
213.94
|
298.55
|
144.40
|
32.68
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
1,175.41
|
16.59
|
14.75
|
65.74
|
-90.99
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-56.05
|
-63.24
|
-171.10
|
-150.67
|
-161.11
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-676.18
|
-3.91
|
43.26
|
273.39
|
184.31
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
443.17
|
-50.56
|
-113.09
|
188.46
|
-67.79
|
|
|
|
|
|
Financials Ratios |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-220.72
|
-3.18
|
40.12
|
35.18
|
31.27
|
26.25
|
|
|
|
|
|
|
Cash EPS (₹)
|
--
|
14.41
|
61.58
|
51.73
|
44.93
|
34.16
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
--
|
376.55
|
374.56
|
341.12
|
307.07
|
254.78
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
3.00
|
3.00
|
3.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
572.34
|
8.08
|
7.18
|
32.01
|
-48.25
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
403.80
|
-104.94
|
-118.70
|
-102.15
|
-126.22
|
|
|
|
|
|
Profitability Ratios |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
15.08
|
13.31
|
11.66
|
11.29
|
11.26
|
|
|
|
|
|
|
ROE (%)
|
-61.43
|
-0.85
|
11.21
|
10.86
|
11.44
|
10.82
|
|
|
|
|
|
|
ROA (%)
|
-3.70
|
-0.27
|
3.67
|
3.86
|
4.33
|
4.28
|
|
|
|
|
|
|
EBIT Margin (%)
|
-39.92
|
-11.43
|
13.97
|
12.36
|
14.69
|
13.99
|
|
|
|
|
|
|
Net Margin (%)
|
-12.35
|
-0.63
|
4.92
|
5.31
|
6.52
|
6.47
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
2.92
|
7.65
|
7.90
|
9.46
|
8.84
|
|
|
|
|
|
Growth Ratios |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-41.01
|
-38.54
|
22.99
|
38.28
|
33.77
|
16.32
|
|
|
|
|
|
|
EBIT Growth (%)
|
-385.73
|
-150.30
|
--
|
16.40
|
40.45
|
16.60
|
|
|
|
|
|
|
Net Profit Growth (%)
|
27.84
|
-107.93
|
14.02
|
13.71
|
34.57
|
-24.24
|
|
|
|
|
|
|
EPS Growth (%)
|
-390.57
|
-107.93
|
14.02
|
12.51
|
19.13
|
-20.59
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
0.53
|
9.80
|
11.09
|
31.26
|
22.51
|
|
|
|
|
|
Valuation Ratios |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
8.12
|
9.62
|
12.47
|
13.68
|
|
|
|
|
|
|
Price / Book Value
|
0.12
|
0.58
|
0.87
|
0.99
|
1.27
|
1.41
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
0.89
|
0.77
|
0.84
|
|
|
|
|
|
|
EV/EBITDA
|
-1.87
|
-13.97
|
6.24
|
7.19
|
8.01
|
9.25
|
|
|
|
|
|
|
Close Price (₹)
|
87.15
|
217.10
|
325.70
|
332.95
|
391.05
|
360.25
|
|
|
|
|
|
|
High Price (₹)
|
273.70
|
380.00
|
474.00
|
435.00
|
440.00
|
383.00
|
|
|
|
|
|
|
Low Price (₹)
|
79.60
|
180.00
|
202.15
|
296.00
|
309.20
|
165.75
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
78.04
|
446.78
|
669.40
|
695.28
|
801.14
|
676.98
|
|
|
|
|
|
Solvency Ratios |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.58
|
1.10
|
1.75
|
1.54
|
1.43
|
1.19
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.48
|
0.34
|
0.58
|
0.56
|
0.51
|
--
|
|
|
|
|
|
|
Current Ratio
|
0.78
|
0.92
|
0.88
|
1.26
|
1.43
|
4.74
|
|
|
|
|
|
|
Quick Ratio
|
0.62
|
0.81
|
0.65
|
0.85
|
1.02
|
3.58
|
|
|
|
|
|
|
Interest Coverage
|
0.63
|
1.02
|
1.67
|
1.90
|
2.23
|
2.07
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Jun-14 | Jun-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
28.49
|
16.42
|
24.25
|
25.57
|
29.26
|
27.07
|
|
|
|
|
|
|
Asset Turnover
|
0.29
|
0.42
|
0.74
|
0.72
|
0.66
|
0.66
|
|
|
|
|
|
|
Receivable days
|
--
|
101.58
|
81.60
|
84.64
|
89.44
|
93.46
|
|
|
|
|
|
|
Inventory Days
|
--
|
67.21
|
59.37
|
72.55
|
72.08
|
58.01
|
|
|
|
|
|
|
Payable days
|
--
|
61.48
|
45.48
|
36.03
|
34.05
|
39.90
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
107.30
|
95.49
|
121.15
|
127.47
|
111.57
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
